Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction

New England Journal of Medicine

Volumn 331, Issue 17, 1994, Pages 1136-1142

  Ayanian, John Z ^a,d   Hauptman, Paul J ^b   Guadagnoli, Edward ^d   Antman, Elliott M ^b   Pashos, Chris L ^d   Mcneil, Barbara J ^c,d  

^a Section on Health Services and Policy Research ^*  (United States)

^b Department of Medicine   (United States)

^c Department of Radiology ^*  (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; FIBRINOLYTIC AGENT; LIDOCAINE;

ACUTE HEART INFARCTION; ARTICLE; COMPARATIVE STUDY; FIBRINOLYTIC THERAPY; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HUMAN; HUMAN EXPERIMENT; MEDICAL SPECIALIST; NORMAL HUMAN; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL RATE;

ADULT; CARDIOLOGY; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNAL MEDICINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW YORK; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; SPECIALTIES, MEDICAL; TEXAS; THROMBOLYTIC THERAPY;

EID: 0028100191     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199410273311707     Document Type: Article

References (49)

1. Starfield B, Simpson L Primary care as part of US health services reform. JAMA 1993; 269: 3136-3139
2. Franks P, Nutting PA, Clancy CM Health care reform, primary care, and the need for research. JAMA 1993; 270: 1449-1453
3. Kimball HR, Young PR A statement on the generalist physician from the American Boards of Family Practice and Internal Medicine. JAMA 1994; 271: 315-316
4. Physician characteristics and distribution in the U.S. Chicago: American Medical Association, 1993.
5. Wennberg JE, Goodman DC, Nease RF, Keller RB Finding equilibrium in U.S. physician supply. Health Aff (Millwood) 1993; 12: 89-103
6. Weiner JP Forecasting the effects of health reform on US physician workforce requirement: evidence from HMO staffing patterns. JAMA 1994; 272: 222-230
7. Kindig DA, Cultice JM, Mullan F The elusive generalist physician: can we reach a 50% goal? JAMA 1993; 270: 1069-1073
8. Cohen JJ Transforming the size and composition of the physician work force to meet the demands of health care reform. N Engl J Med 1993; 329: 1810-1812
9. National Center for Health Statistics. Health, United States, 1990. Hyattsville, Md.: Public Health Service, 1991. (DHHS publication no. (PHS) 91-1232.)
10. Graves EJ. 1991 Summary: National Hospital Discharge Survey. Hyattsville, Md.: National Center for Health Statistics, 1993. (DHHS publication no. (PHS) 93-1250.)
11. Yusuf S, Wittes J, Friedman L Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988; 260: 2088-2093
12. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248-254
13. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402
14. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360
15. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988; 296: 320-331
16. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-807
17. (beta)-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247: 1707-1714
18. Yusuf S, Peto R, Lewis J, Collins R, Sleight P Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-371
19. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 1988; 260: 1910-1916
20. Hine LK, Laird N, Hewitt P, Chalmers TC Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 1989; 149: 2694-2698
21. The Danish Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction. Eur Heart J 1984; 5: 516-528
22. The Israeli Sprint Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT): a randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988; 9: 354-364
23. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988; 319: 385-392
24. Held PH, Yusuf S, Furberg CD Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ 1989; 299: 1187-1192
25. Tognoni G, Franzosi MG, Garattini S, The case of GISSI in changing the attitudes and practice of Italian cardiologists. Stat Med 1990; 9: 17-27
26. Lamas GA, Pfeffer MA, Hamm P, Wertheimer J, Rouleau J-L, Braunwald E Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med 1992; 327: 241-247
27. Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med 1992; 93: 605-610
28. Pashos CL, Normand SL, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol 1994; 23: 1023-1030
29. Hutchison SJ, Cobbe SM Management of myocardial infarction in Scotland: have clinical trials changed practice? BMJ 1987; 294: 1261-1261
30. Hlatky MA, Cotugno H, O'Connor C, Mark DB, Pryor DB, Califf RM Adoption of thrombolytic therapy in the management of acute myocardial infarction. Am J Cardiol 1988; 61: 510-514
31. Hlatky MA, Cotugno HE, Mark DB, O'Connor C, Califf RM, Pryor DB Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Am J Cardiol 1988; 61: 515-518
32. Bureau of the Census. Statistical abstract of the United States: 1993. 113th ed. Washington, D.C.: Government Printing Office, 1993:33.
33. Aday LA. Designing and conducting health surveys: a comprehensive guide. San Francisco: Jossey-Bass, 1989:121-4.
34. SAS/STAT user's guide: version 6. 4th ed. Cary, N.C.: SAS Institute, 1990.
35. Stross JK, Harlan WR The dissemination of new medical information. JAMA 1979; 241: 2622-2624
36. Stinson ER, Mueller DA Survey of health professionals' information habits and needs. JAMA 1980; 243: 140-143
37. Stross JK, Harlan WR Dissemination of relevant information on hypertension. JAMA 1981; 246: 360-362
38. Gunnar RM, Passamani ER, Bourdillon PD, Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol 1990; 16: 249-292
39. Gunnar RM, Bourdillon PD, Dixon DW, ACC/AHA guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. Circulation 1990; 82: 664-707
40. Mitchell JRA “But will it help my patients with myocardial infarction?” The implications of recent trials for everyday country folk. BMJ 1982; 285: 1140-1148
41. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA 1992; 268: 240-248
42. Young MJ, Fried LS, Eisenberg J, Hershey J, Williams S Do cardiologists have higher thresholds for recommending coronary arteriography than family physicians? Health Serv Res 1987; 22: 623-635
43. Wennberg JE, Freeman JL, Culp WJ Are hospital services rationed in New Haven or over-utilised in Boston? Lancet 1987; 1: 1185-1189
44. Chassin MR, Kosecoff J, Park RE, Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA 1987; 258: 2533-2537
45. Naylor CD, Hollenberg AA, Ugnat AM, Basinski A Coronary thrombolysis -- clinical guidelines and public policy: results of an Ontario practitioner survey. Can Med Assoc J 1990; 142: 1069-1076
46. Thompson PL, Parsons RW, Jamrozik K, Hockey RL, Hobbs MST, Broadhurst RJ Changing patterns of medical treatment in acute myocardial infarction: observations from the Perth MONICA Project 1984-1990. Med J Aust 1992; 157: 87-92
47. Elkhatib A, Grines CL, Schreiber T, O'Neill W Cardiology versus internal medicine management of unstable angina patients: treatment patterns and outcome. Circulation 1993; 88: Suppl I: I-608 abstract.
48. Soumerai SB, McLaughlin TJ, Avorn J Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q 1989; 67: 268-317
49. Greco PJ, Eisenberg JM Changing physicians' practices. N Engl J Med 1993; 329: 1271-1273